Back to search results

Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

CNS Lymphoma · Primary Central Nervous System Lymphoma · Secondary Central Nervous System Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of California, San Francisco, San Francisco, California, United States

    Contact: Study coordinator (UCSF Hematopoietic Malignancies Clinical Trial Recruitment) · HDFCCC.Heme@ucsf.edu · 877-827-3222
    Study coordinator · cancertrials@ucsf.edu
    Contact: Principal Investigator (James Rubenstein, MD, PhD)
Study leads

  • James Rubenstein, MD, PhD

    Principal Investigator

    University of California, San Francisco

View source on ClinicalTrials.gov(opens in a new tab)